No Picture
News

Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting

BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the presentation of new long term follow-up […]

No Picture
News

GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt)

YONGIN, South Korea and AUSTIN, Texas, Sept. 28, 2022 /PRNewswire/ — GC Labs, a leading South Korea clinical laboratory, today announced that it has recently obtained certification of standardization programs from the U.S. Centers for […]

No Picture
News

bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M

SAN ANTONIO, Texas–(BUSINESS WIRE)– #BIAF–bioAffinity Technologies receives additional $7.7M from exercise of warrants, increasing total capital from IPO to approximately $15.6M Click here to view original post

No Picture
News

Caris’ Precision Oncology Alliance Welcomes Indiana University Melvin and Bren Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center joins Caris’ extensive network of leading cancer institutions committed to utilizing clinical data to advance patient care and outcomes IRVING, Texas, Sept. 28, 2022 /PRNewswire/ — Caris Life Sciences®(Caris), the […]